Triple combination therapy group
2018-NFMDXK-003
Approved small_molecule completed
Quick answer
Triple combination therapy group for Type 2 Diabetes Mellitus is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed